MicroRNA-1 Regulates the Differentiation of Adipose-Derived Stem Cells into Cardiomyocyte-Like Cells.
Can ChenQuanxiang YanYiguang YanMudi MaYuan HeXiaorong ShuiZhigang YangXiaozhong LanYao Liang TangWei LeiPublished in: Stem cells international (2018)
Stem cell transplantation is one of most valuable methods in the treatment of myocardial infarction, and adipose-derived stem cells (ASCs) are becoming a hot topic in medical research. Previous studies have shown that ASCs can be differentiated into cardiomyocyte-like cells, but the efficiency and survival rates are low. We investigated the role and mechanism of microRNA-1 (miR-1) in the differentiation of ASCs into cardiomyocyte-like cells. ASCs and cardiomyocytes were isolated from neonatal rats. We constructed lentivirus for overexpressing miR-1 and used DAPT, an antagonist of the Notch1 pathway, for in vitro analyses. We performed cocultures with ASCs and cardiomyocytes. The differentiation efficiency of ASCs was detected by cell-specific surface antigens. Our results showed that miR-1 can promote the expression of Notch1 and reduce the expression of Hes1, a Notch pathway factor, and overexpression of miR-1 can promote the differentiation of ASCs into cardiomyocyte-like cells, which may occur by regulating Notch1 and Hes1.
Keyphrases
- cell proliferation
- long non coding rna
- stem cell transplantation
- poor prognosis
- long noncoding rna
- high glucose
- angiotensin ii
- high dose
- healthcare
- single cell
- endothelial cells
- stem cells
- binding protein
- cell therapy
- transcription factor
- antiplatelet therapy
- wastewater treatment
- percutaneous coronary intervention
- case control
- free survival